BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22348853)

  • 1. Coleman, Coyle, Shuping, and Rue make false statements and draw erroneous conclusions in analyses of abortion and mental health using the National Comorbidity Survey.
    Steinberg JR; Finer LB
    J Psychiatr Res; 2012 Mar; 46(3):407-8; discussion 408-11. PubMed ID: 22348853
    [No Abstract]   [Full Text] [Related]  

  • 2. Examining the association of abortion history and current mental health: A reanalysis of the National Comorbidity Survey using a common-risk-factors model.
    Steinberg JR; Finer LB
    Soc Sci Med; 2011 Jan; 72(1):72-82. PubMed ID: 21122964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induced abortion and anxiety, mood, and substance abuse disorders: isolating the effects of abortion in the national comorbidity survey.
    Coleman PK; Coyle CT; Shuping M; Rue VM
    J Psychiatr Res; 2009 May; 43(8):770-6. PubMed ID: 19046750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abortion and mental health: findings from The National Comorbidity Survey-Replication.
    Steinberg JR; McCulloch CE; Adler NE
    Obstet Gynecol; 2014 Feb; 123(2 Pt 1):263-270. PubMed ID: 24402590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Other mental disorders presenting together with schizophrenia].
    Koponen H; Moilanen K; Isohanni M
    Duodecim; 2003; 119(1):43-9. PubMed ID: 12607471
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Grant BF; Stinson FS; Dawson DA; Chou SP; Dufour MC; Compton W; Pickering RP; Kaplan K
    Arch Gen Psychiatry; 2004 Aug; 61(8):807-16. PubMed ID: 15289279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of mood, anxiety, and substance-abuse disorders for older Americans in the national comorbidity survey-replication.
    Gum AM; King-Kallimanis B; Kohn R
    Am J Geriatr Psychiatry; 2009 Sep; 17(9):769-81. PubMed ID: 19700949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding comorbidity between substance use, anxiety and affective disorders: broadening the research base.
    Hall W; Degenhardt L; Teesson M
    Addict Behav; 2009; 34(6-7):526-30. PubMed ID: 19386422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy of comorbid mood, anxiety, and substance use disorders.
    Brady KT; Verduin ML
    Subst Use Misuse; 2005; 40(13-14):2021-41, 2043-8. PubMed ID: 16282091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of anxiety disorders in the Australian general population: findings of the 2007 Australian National Survey of Mental Health and Wellbeing.
    McEvoy PM; Grove R; Slade T
    Aust N Z J Psychiatry; 2011 Nov; 45(11):957-67. PubMed ID: 22044173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance use disorders comorbid with mood and anxiety disorders in the Australian general population.
    Prior K; Mills K; Ross J; Teesson M
    Drug Alcohol Rev; 2017 May; 36(3):317-324. PubMed ID: 27324816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comorbidity in Australia: findings of the 2007 National Survey of Mental Health and Wellbeing.
    Teesson M; Slade T; Mills K
    Aust N Z J Psychiatry; 2009 Jul; 43(7):606-14. PubMed ID: 19530017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabis Use and Risk for Substance Use Disorders and Mood or Anxiety Disorders.
    Hill KP
    JAMA; 2017 Mar; 317(10):1070-1071. PubMed ID: 28291877
    [No Abstract]   [Full Text] [Related]  

  • 14. Temporal sequencing of lifetime mood disorders in relation to comorbid anxiety and substance use disorders--findings from the Netherlands Mental Health Survey and Incidence Study.
    de Graaf R; Bijl RV; Spijker J; Beekman AT; Vollebergh WA
    Soc Psychiatry Psychiatr Epidemiol; 2003 Jan; 38(1):1-11. PubMed ID: 12563553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Conway KP; Compton W; Stinson FS; Grant BF
    J Clin Psychiatry; 2006 Feb; 67(2):247-57. PubMed ID: 16566620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bridging the clinical gap: managing patients with co-occurring mood, anxiety, and alcohol use disorders. Introduction.
    Schatzberg AF; Weiss RD; Brady KT; Culpepper L
    CNS Spectr; 2008 Apr; 13(4 Suppl 6):3. PubMed ID: 18408653
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathways to comorbidity: the transition of pure mood, anxiety and substance use disorders into comorbid conditions in a longitudinal population-based study.
    de Graaf R; Bijl RV; Ten Have M; Beekman AT; Vollebergh WA
    J Affect Disord; 2004 Nov; 82(3):461-7. PubMed ID: 15555699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Help-seeking for substance use, anxiety and affective disorders among young people: results from the 2007 Australian National Survey of Mental Health and Wellbeing.
    Reavley NJ; Cvetkovski S; Jorm AF; Lubman DI
    Aust N Z J Psychiatry; 2010 Aug; 44(8):729-35. PubMed ID: 20636194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychiatric comorbidity of full and partial posttraumatic stress disorder among older adults in the United States: results from wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions.
    Pietrzak RH; Goldstein RB; Southwick SM; Grant BF
    Am J Geriatr Psychiatry; 2012 May; 20(5):380-90. PubMed ID: 22522959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Common Mental Disorders in the United States: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III.
    Olfson M; Blanco C; Wall MM; Liu SM; Grant BF
    J Clin Psychiatry; 2019 May; 80(3):. PubMed ID: 31141319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.